Problems
What will AGI do for Biologic Therapy Reimbursement?
Specialty clinics and infusion centers lose millions in uncollected revenue and staff time attempting to secure reimbursement for biologic therapies. Unlike standard pharmaceuticals, biologics require exhaustive prior authorization packets proving medical necessity, often demanding evidence that cheaper therapies have failed. Care coordinators manually dig through months of unstructured clinical notes, lab results, and patient histories to build these submissions.